Oura, the Finnish smart ring maker, is targeting a September initial public offering that would value the company at over $16 billion, according to reports. The move marks a major milestone for the biometric wearables company, which has built one of the most recognizable connected health devices on the market.
Oura manufactures rings embedded with sensors that track sleep, heart rate variability, body temperature, and other health metrics. The company ships data to an app where users monitor their readiness, sleep quality, and recovery scores. The product gained mainstream attention during the pandemic as consumers invested in personal health tracking and wellness monitoring.
The reported $16 billion valuation represents a substantial jump from Oura's last known valuation. The company raised $100 million in Series C funding in 2021 at a $2.55 billion valuation, led by Google Ventures and including participation from Khosla Ventures and other backers. A later funding round in 2023 put the company's valuation at roughly $5.2 billion, according to reports at the time. This new IPO valuation nearly triples that figure.
The timing suggests Oura believes market conditions are favorable for a public debut. Recent months have seen increased investor appetite for healthcare and wellness tech companies, particularly those with large installed user bases and recurring revenue models. Oura has sold hundreds of thousands of rings globally and maintains a subscription service that generates predictable recurring revenue.
Oura faces competition from established wearables makers including Apple Watch, which added sleep tracking capabilities, and Whoop, a fitness-focused wearable band backed by venture capital and high-profile athletes. Oura differentiates through form factor, brand prestige among health-conscious consumers, and a dedicated focus on sleep and recovery metrics rather than exercise tracking.
The company has been expanding its product line and partnerships. Oura launched the Ring 3 in late 2021 and a subsequent generation since then. It also signed corporate wellness partnerships and pursued clinical research to validate its health insights, bolstering its credibility with both consumers and insurance companies.
An IPO in September would require Oura to move quickly through the SEC registration process. The company would need to file an S-1 form, undergo investor roadshow activities, and price shares ahead of that target date. Public market debuts for venture-backed companies have remained steady despite broader economic uncertainty, though valuations have moderated compared to peak 2021 levels.
If Oura achieves a $16 billion valuation at IPO, it would represent one of the largest public debuts for a hardware-focused health company. The valuation bet reflects investor confidence in the connected health category and Oura's position as the category leader in smart rings.